Influence of genetic and non-genetic factors on phenytoin-induced severe cutaneous adverse drug reactions
- 8 April 2017
- journal article
- research article
- Published by Springer Nature in European Journal of Clinical Pharmacology
- Vol. 73 (7) , 855-865
Abstract
Purpose The purpose of this study was to investigate the association of genetic factors including variants in HLA-B and CYP2C genes and non-genetic factors with phenotype-specific phenytoin (PHT)-induced severe cutaneous adverse reactions (SCARs) in Thai patients. Methods Thirty-six PHT-induced SCAR cases (15 Stevens-Johnson syndrome (SJS) and 21 drug rash with eosinophilia and systemic symptoms (DRESS)/drug hypersensitivity syndrome (DHS)) and 100 PHT-tolerant controls were studied. Variants in HLA-B, CYP2C9, and CYP2C19 genes were genotyped. Fisher’s exact test and multiple logistic regression analysis were performed to test the association of genetic and non-genetic factors with specific type of SCARs. Results Multiple logistic regression models showed that genetic and non-genetic factors associated with PHT-induced SCARs were specified to its phenotype. HLA-B*13:01, HLA-B*56:02/04, CYP2C19*3, and omeprazole co-medication were strong risk factors of DRESS/DHS (adjusted OR = 13.29, p = 0.0001; adjusted OR = 56.23, p = 0.0007; adjusted OR = 6.75, p = 0.0414; and adjusted OR = 9.21, p = 0.0020, respectively). While CYP2C9*3 and having Chinese ancestry were significant risk factors of SJS (adjusted OR = 10.41, p = 0.0042 and adjusted OR = 5.40, p = 0.0097, respectively). Combined genetic and non-genetic risk factors optimized sensitivity and increased specificity for predicting PHT-induced SCARs. Conclusion This study showed that distinct genetic markers were associated with phenotype-specific PHT-induced SCARs. Non-genetic factor, omeprazole co-medication, was strongly associated with PHT-induced DRESS/DHS in addition to variants in HLA-B and CYP2C genes. Combined markers may be better predictors for PHT-induced SCARs.Keywords
Funding Information
- THE 90th ANNIVERSARY OF CHULALONGKORN UNIVERSITY FUND (GCUCR1125572100M No.86)
- Ratchadaphiseksomphot Endowment Fund of Chulalongkorn University
This publication has 38 references indexed in Scilit:
- CYP2C19 polymorphisms in the Thai population and the clinical response to clopidogrel in patients with atherothrombotic-risk factorsPharmacogenomics and Personalized Medicine, 2013
- PharmGKB summaryPharmacogenetics and Genomics, 2012
- CYP2C9 Amino Acid Residues Influencing Phenytoin Turnover and Metabolite Regio- and StereochemistryThe Journal of Pharmacology and Experimental Therapeutics, 2009
- Comparison and predictors of rash associated with 15 antiepileptic drugsNeurology, 2007
- Predictors of Lamotrigine‐associated RashEpilepsia, 2006
- High-throughput DNA typing of HLA-A, -B, -C, and -DRB1 loci by a PCR–SSOP–Luminex method in the Japanese populationImmunogenetics, 2005
- A marker for Stevens–Johnson syndromeNature, 2004
- Convergence Problems in Logistic Regression2003
- Anticonvulsant Hypersensitivity SyndromeDrug Safety, 1999
- The Spectrum of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: A Clinical Classification.Journal of Investigative Dermatology, 1994